Vnitr Lek 2014, 60(10):908-910
Aktualizované stanovisko České společnosti pro hypertenzi k provádění renálních denervací u rezistentní hypertenze
- 1 II. interní klinika LF UK a FN Plzeň, přednosta prof. MUDr. Jan Filipovský, CSc.
- 2 Interní klinika 1. LF UK a ÚVN - Vojenská fakultní nemocnice Praha, přednosta prof. MUDr. Miroslav Zavoral, Ph.D.
- 3 Synlab Czech s.r.o., Interní, diabetologická a nefrologická ambulance, Praha
- 4 III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
Received: October 7, 2014; Published: October 1, 2014 Show citation
References
- Widimský P, Filipovský J, Widimský J jr et al. Odborné stanovisko České kardiologické společnosti a České společnosti pro hypertenzi k provádění katetrizačních renálních denervací (RDN) v České republice. Hypertenze a Kardiovaskulární prevence 2012; 1(1): 5-9. Cor et Vasa 2012; 54(3-4): 155-159.
Go to original source...
- Esler MD, Krum H, Sobotka PA et al. Renal sympathetic denervation in patients with treatment - resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376(9756): 1903-1909.
Go to original source...
Go to PubMed...
- Bhatt DL, Kandzari DE, O'Neill WW et al. on behalf of the SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370(15): 1393-1401.
Go to original source...
Go to PubMed...
- Persu A, Jin Y, Azizi M et al. European Network COordinating research on Renal Denervation (ENCOReD). Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens 2014; 28(3): 150-156.
Go to original source...
Go to PubMed...
- Toušek P, Widimský J jr, Rosa J et al. Catheter-based renal denervation versus intensified medical treatment in patients with resistant hypertension: Rationale and design of a multicenter randomised study - Prague-15. Cor et Vasa 2014; 56(2): e235-e239. Dostupné z WWW: <http://www.e-coretvasa.cz/casopis/view?id=5617>.
Go to original source...
- Fadl Elmula FE, Hoffmann P, Larstorp AC et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension 2014; 63(5): 991-999.
Go to original source...
Go to PubMed...
- Ezzahti M, Moelker A, Friesema ECH et al. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension. J Hypertension 2014; 32(1): 135-141.
Go to original source...
Go to PubMed...
- Papademetriou V, Tsioufis CP, Sinhal A et al. Catheter-Based Renal Denervation for Resistant Hypertension: 12-Month Results of the EnligHTN I First-in-Human Study Using a Multielectrode Ablation System. Hypertension 2014; 64(3): 565-572.
Go to original source...
Go to PubMed...
- Persu A, Jin Y, Baelen M et al. on behalf of the European Network Coordinating research on REnal Denervation (ENCOReD) Consortium. Eligibility for renal denervation. Experience at 11 European Expert Centers. Hypertension 2014; 63(6): 1319-1325.
Go to original source...
Go to PubMed...
- Rosa J, Zelinka T, Petrák O et al. Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? J Human Hypertension 2014 28(11): 684-688. doi: 10.1038/jhh.2014.3.
Go to original source...
Go to PubMed...
- Templin C, Jaguszewski M, Ghadri JR et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN multi-electrode renal denervation catheter. Eur Heart J 2013; 34(28): 2141-2148.
Go to original source...
Go to PubMed...